Vesalius Therapeutics, a buzzy, Flagship-backed startup, cuts jobs six months after public launch
Bio Pharma Dive
SEPTEMBER 20, 2022
When the company debuted in March, it announced plans to hire 200 employees over two years. Now, it’s laid off nearly half its staff in a year when the biotech sector has experienced a sharp market downturn.
Let's personalize your content